{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:41:12Z","timestamp":1775130072225,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T00:00:00Z","timestamp":1397692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T00:00:00Z","timestamp":1397692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2014,10,1]]},"DOI":"10.1038\/jhh.2014.19","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T09:25:07Z","timestamp":1397726707000},"page":"575-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of eplerenone on insulin action in essential hypertension: a randomised, controlled, crossover study"],"prefix":"10.1038","volume":"28","author":[{"given":"E M","family":"McMurray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I R","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S J","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A B","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P M","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,17]]},"reference":[{"key":"BFjhh201419_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00004872-199816110-00012","volume":"16","author":"IM Wiggam","year":"1998","unstructured":"Wiggam IM, Hunter SJ, Atkinson AB, Ennis CN, Henry JS, Browne JN et al. Captopril does not improve insulin action in essential hypertension: a double-blind placebo controlled study. J Hypertens 1998; 16: 103\u2013109.","journal-title":"J Hypertens"},{"key":"BFjhh201419_CR2","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00125-006-0458-2","volume":"49","author":"GH Goossens","year":"2006","unstructured":"Goossens GH, Blaak EE, Schiffers PM, Saris WHM, van Baak MA . Effect of short-term ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects. Diabetologia 2006; 49: 3009\u20133016.","journal-title":"Diabetologia"},{"key":"BFjhh201419_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM200003303421301","volume":"342","author":"TW Gress","year":"2000","unstructured":"Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL . Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. New Engl J Med 2000; 342: 905\u2013912.","journal-title":"New Engl J Med"},{"key":"BFjhh201419_CR4","first-page":"1882","volume":"85","author":"JR Petrie","year":"2000","unstructured":"Petrie JR, Morris AD, Ueda S, Small M, Donnell R, Connell JMC et al. Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: A double-blind, placebo-controlled crossover trial. J Clin Endocrinol Metab 2000; 85: 1882\u20131889.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201419_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00004872-199917030-00018","volume":"17","author":"F Galletti","year":"1999","unstructured":"Galletti F, Strazzullo P, Capaldo B, Fabris F, Ferrara LA, Gloriosa N et al. Controlled study of the effect of angiotension converting enzyme inhibiton versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Itatlian Study (TRIS). J Hypertens 1999; 17: 439\u2013445.","journal-title":"J Hypertens"},{"key":"BFjhh201419_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12325-011-0040-2","volume":"28","author":"Y Mori","year":"2011","unstructured":"Mori Y, Tanaka T, Matsuura K, Yokoyama J, Utsunomiya K . Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE). Adv Ther 2011; 28: 698\u2013706.","journal-title":"Adv Ther"},{"key":"BFjhh201419_CR7","doi-asserted-by":"crossref","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 14): S5\u2013S20.","DOI":"10.2337\/diacare.26.2007.S5"},{"key":"BFjhh201419_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tem.2005.02.003","volume":"16","author":"G Giacchetti","year":"2005","unstructured":"Giacchetti G, Sechi LA, Rilli S, Carey R . The renin\u2013angiotensin\u2013aldosterone system, glucose metabolism and diabetes. Trends Endocrin Metab 2005; 16: 120\u2013126.","journal-title":"Trends Endocrin Metab"},{"issue":"11","key":"BFjhh201419_CR9","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2007-1088","volume":"92","author":"R Bentley-Lewis","year":"2007","unstructured":"Bentley-Lewis R, Adler GK, Perlstein T, Seely EW, Hopkins PN, Williams GH et al. Body mass index predicts aldosterone production in normotensive adults on a high salt diet. J Clin Endocrinol Metab 2007; 92 (11): 4472\u20134475.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"BFjhh201419_CR10","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1210\/jc.2009-2521","volume":"95","author":"R Garg","year":"2010","unstructured":"Garg R, Hurwitz S, Williams GH, Hopkins PN, Adler GK . Aldosterone production and insulin resistance in healthy adults. J Clin Endocrinol Metab 2010; 95 (4): 1986\u20131990.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201419_CR11","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1210\/jc.2006-0736","volume":"91","author":"C Catena","year":"2006","unstructured":"Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G-L, Novello M et al. Insulin sensitivity in patients with primary aldosteronism: a follow up study. J Clin Endocrinol Metab 2006; 91: 3457\u20133463.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201419_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"BP Pitt","year":"2003","unstructured":"Pitt BP, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 2003; 348: 1309\u20131321.","journal-title":"New Engl J Med"},{"issue":"1","key":"BFjhh201419_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zanad","year":"2011","unstructured":"Zanad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H et al. Eplerenone in patients with systolic heart failure and mild symptoms. New Engl J Med 2011; 364 (1): 11\u201321.","journal-title":"New Engl J Med"},{"issue":"17","key":"BFjhh201419_CR14","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","volume":"117","author":"C Guo","year":"2008","unstructured":"Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR et al. Mineralocoticoid receptor blockade reverses obesity-related changes in expressions of adiponectin, peroxisome proliferator-activated receptor-\u03b3 and pro-inflammatory adipokines. Circulation 2008; 117 (17): 2253\u20132261.","journal-title":"Circulation"},{"key":"BFjhh201419_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s001250050363","volume":"38","author":"R Harper","year":"1995","unstructured":"Harper R, Ennis CN, Heany AP, Sheridan B, Gormley M, Atkinson AB et al. A comparison of the effects of low and conventional dose thiazide diuretic on insulin action in hypertensive patients with NIDDM. Diabetologia 1995; 38: 853\u2013859.","journal-title":"Diabetologia"},{"issue":"9","key":"BFjhh201419_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0026-0495(03)00190-2","volume":"52","author":"CH Courtney","year":"2003","unstructured":"Courtney CH, McCance DR, Atkinson AB, Bassett J, Ennis CN, Sheridan B et al. Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action. Metabolism 2003; 52 (9): 1147\u20131152.","journal-title":"Metabolism"},{"key":"BFjhh201419_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/BF00400570","volume":"33","author":"RD Neely","year":"1990","unstructured":"Neely RD, Rooney DP, Atkinson AB, Sheridan B, Ennis CN, Trimble ER et al. Underestimation of glucose turnover determined using (6-3H) glucose tracer in non-steady state. The role of a tritiated tracer impurity. Diabetologia 1990; 33: 681\u2013687.","journal-title":"Diabetologia"},{"key":"BFjhh201419_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/bmj.309.6949.226","volume":"309","author":"R Harper","year":"1994","unstructured":"Harper R, Ennis CN, Sheridan B, Atkinson AB, Johnston GD, Bell PM . Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. BMJ 1994; 309: 226\u2013230.","journal-title":"BMJ"},{"key":"BFjhh201419_CR19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0021-9258(18)43098-0","volume":"160","author":"M Somogyi","year":"1945","unstructured":"Somogyi M . Determination of blood sugar. J Biol Chem 1945; 160: 69\u201373.","journal-title":"J Biol Chem"},{"key":"BFjhh201419_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1152\/ajplegacy.1956.187.1.15","volume":"1987","author":"R Steele","year":"1956","unstructured":"Steele R, Wall JS, DeBodo RC, Atlszuler N . Measurement of size and turnover rate of body glucose pool by the dilutional method. Am J Physiol 1956; 1987: 15\u201324.","journal-title":"Am J Physiol"},{"key":"BFjhh201419_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2337\/diab.12.1.16","volume":"12","author":"RC DeBodo","year":"1963","unstructured":"DeBodo RC, Stelle R, Altszuler N, Dunn A, Bishop JS . Effects of insulin on hepatic glucose metabolism and glucose utilization by tissue. Diabetes 1963; 12: 16\u201330.","journal-title":"Diabetes"},{"key":"BFjhh201419_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-2125.1979.tb05903.x","volume":"8","author":"M Hills","year":"1979","unstructured":"Hills M, Armitage P . The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8: 7\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"BFjhh201419_CR23","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R . Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237 (3): E214\u2013E223.","journal-title":"Am J Physiol"},{"key":"BFjhh201419_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","volume":"49","author":"N Chapman","year":"2007","unstructured":"Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007; 49: 839\u2013845.","journal-title":"Hypertension"},{"key":"BFjhh201419_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 1999; 341: 709\u2013717.","journal-title":"New Engl J Med"},{"key":"BFjhh201419_CR26","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","volume":"28","author":"K Rossing","year":"2005","unstructured":"Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving H-H . Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy. Diabetes Care 2005; 28: 2106\u20132112.","journal-title":"Diabetes Care"},{"issue":"1","key":"BFjhh201419_CR27","first-page":"21","volume":"108","author":"G Sindelka","year":"2000","unstructured":"Sindelka G, Widimsky J, Haas T, Pazny M, Hilgertova J, Skrha J . Insulin action in primary hyperaldosteronsim before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes 2000; 108 (1): 21\u201325.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"BFjhh201419_CR28","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","volume":"47","author":"JI Davies","year":"2004","unstructured":"Davies JI, Band M, Morris A, Struthers AD . Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia 2004; 47 (10): 1687\u20131694.","journal-title":"Diabetologia"},{"issue":"5","key":"BFjhh201419_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s00125-008-0972-5","volume":"51","author":"K Swaminathan","year":"2008","unstructured":"Swaminathan K, Davies J, George J, Rajendra NS, Morris AD, Struthers AD . Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles. Diabetologia 2008; 51 (5): 762\u2013768.","journal-title":"Diabetologia"},{"key":"BFjhh201419_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ahj.2010.04.024","volume":"160","author":"M Yamaji","year":"2010","unstructured":"Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M et al. Effect of eplerenone versus spironolactone on cortisol and haemoglobin A1c levels in patients with chronic heart failure. Am Heart J 2010; 160: 915\u2013921.","journal-title":"Am Heart J"},{"key":"BFjhh201419_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/eurjhf\/hfs067","volume":"14","author":"D Preiss","year":"2012","unstructured":"Preiss D, van Veldhuisen DJ, Sattar N, Krum H, Swedberg K, Shi H et al. Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Eu J Heart Fail 2012; 14: 909\u2013915.","journal-title":"Eu J Heart Fail"},{"key":"BFjhh201419_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF . Primary aldosteronism; renaissance of a syndrome. Clin Endocrinol 2007; 66: 607\u2013618.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"BFjhh201419_CR33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ . Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45 (8): 1243\u20131248.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201419","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T18:32:22Z","timestamp":1647541942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,17]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10,1]]}},"alternative-id":["BFjhh201419"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2014.19","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,17]]},"assertion":[{"value":"19 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}